Vifor Pharma AG (VIFN:SW) (GNHAY) PT Lowered to CHF129 at UBS
UBS analyst Laura Sutcliffe lowered the price target on Vifor Pharma AG (VIFN:SW) (OTC: GNHAY) to CHF129.00 (from CHF142.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Tata Consultancy Services Ltd. (TCS:IN) PT Raised to INR4,050 at CLSA
- SCG Packaging PCL (SCGP:TB) PT Raised to THB69 at Macquarie
- APA Group (APA:AU) (APAJF) PT Lowered to AUD8.80 at Credit Suisse
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Intl Ratings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!